4//SEC Filing
Bone Biologics Corp 4
Accession 0001209191-15-087442
$BBLGCIK 0001419554operating
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 8:41 PM ET
Size
8.1 KB
Accession
0001209191-15-087442
Insider Transaction Report
Form 4
Walsh Deina H
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-12-28+239,825→ 239,825 totalExercise: $1.59Exp: 2025-12-27→ Common Stock (239,825 underlying) - Award
Employee Stock Option (Right to Buy)
2015-12-28+465,795→ 465,795 totalExercise: $1.59Exp: 2025-12-27→ Common Stock (465,795 underlying)
Footnotes (2)
- [F1]159,883 shares subject to the option are immediately exercisable and the remaining shares subject to the option shall vest and become exercisable on November 4, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2015 Equity Incentive Plan (the "Plan")) on such vesting date.
- [F2]1/3 of the shares subject to the option shall vest and become exercisable on each of December 1, 2016, December 1, 2017 and December 1, 2018, subject to the Reporting Person's Continuous Service (as defined in the Plan) on each such vesting date.
Documents
Issuer
Bone Biologics Corp
CIK 0001419554
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001419554
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 8:41 PM ET
- Size
- 8.1 KB